Stay updated on Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.

Latest updates to the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated to version 2.16.0, indicating a new revision. The previous version, 2.15.2, has been removed.SummaryDifference0.2%
- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check42 days agoChange DetectedThe webpage has been updated to reflect a new clinical trial involving Pembrolizumab and a new treatment approach for advanced melanoma, with significant details about the study's objectives, collaborators, and eligibility criteria being added. The previous trial information regarding LN-144 (Lifileucel) has been removed.SummaryDifference56%
- Check50 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 8, 2025, while a date of March 25, 2025, has been removed.SummaryDifference0.3%
- Check57 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous estimated update date of January 8, 2025, and revision version 2.14.2.SummaryDifference0.2%
- Check93 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
Stay in the know with updates to Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.